Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors

Clinical trial NCT05415475 · COMPLETED

Trial details

NCT number: NCT05415475
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Esophageal Cancer Stomach Cancer Pancreatic Cancer Metastatic Tumor Recurrent Cancer

Start date: 2021-09-10
Primary completion: 2025-06-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.